Fukushima Medical University · Faculty of Medicine · 准教授

Research keywordspulmonary hypertension・right ventricular dysfunction・respiratory comorbidity・vascular inflammation・hemodynamic biomarkers・epoprostenol therapy

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Targeting colony-stimulating factor-1 receptor attenuates the development of pulmonary arterial hypertension through C-C motif chemokine ligand 22026 · Kazuto Nishiura, Tetsuro Yokokawa, Shohei Ichimura, Shunsuke Miura, Akihiko Sato, Takeshi Shimizu, Tomofumi Misaka, Masayoshi Oikawa, Akiomi Yoshihisa, Koichi Sugimoto, Satoshi Muto, Hiroyuki Suzuki, Koki Ueda, Kazuhiko Ikeda, Kazuhiko Nakazato, Takafumi Ishida, Yasuchika Takeishi
• Collagen triple helix repeat-containing protein 1 is a novel biomarker of right ventricular involvement in pulmonary hypertension2024 · Tetsuro Yokokawa, Kazuto Nishiura, Masataka Katahira, Yu Sato, Shunsuke Miura, Akihiko Sato, Takeshi Shimizu, Tomofumi Misaka, Takamasa Sato, Takashi Kaneshiro, Masayoshi Oikawa, Akiomi Yoshihisa, Koichi Sugimoto, Kenji Fukushima, Kazuhiko Nakazato, Yasuchika Takeishi
• Aberrant phosphorylation of human LRH1 at serine 510 is predictable of hepatocellular carcinoma recurrence.2023 · Nishimagi A, Kobayashi M, Sugimoto K, Kofunato Y, Sato N, Haga J, Ishigame T, Kimura T, Kenjo A, Kobayashi Y, Hashimoto Y, Marubashi S, Chiba H
• Effect of ipragliflozin on endothelial dysfunction in patients with type 2 diabetes and chronic kidney disease: A randomized clinical trial (PROCEED).2023 · Tanaka A, Okada Y, Torimoto K, Kamei N, Hirai H, Kono T, Sugimoto K, Teragawa H, Taguchi I, Maruhashi T, Sonoda S, Kurozumi A, Inagaki S, Oshita C, Hisauchi I, Takahashi K, Higashi Y, Shimabukuro M, Node K, PROCEED Trial Investigators

• MT1-MMPの役割からみた肺高血圧の分子病態と新規治療戦略2012 · 2012年7月
• 血管炎症における新規分子MT1-MMPの関与2010 · 2010年
• 酸化LDLによる血管内皮機能不全の分子機構解明に関する研究2008 · 2008年
• 高脂血症による血管内皮細胞機能不全の分子メカニズムの解明と治療戦略2007 · 2007年

• Official profile